Shares of Cullinan Management, Inc. (NASDAQ:CGEM) saw unusually-strong trading volume on Thursday . Approximately 9,250 shares changed hands during mid-day trading, a decline of 97% from the previous session’s volume of 300,581 shares.The stock last traded at $35.94 and had previously closed at $35.14.

A number of analysts recently issued reports on CGEM shares. SVB Leerink started coverage on Cullinan Management in a research report on Tuesday, February 2nd. They issued an “outperform” rating and a $52.00 price target for the company. Morgan Stanley initiated coverage on Cullinan Management in a research report on Tuesday, February 2nd. They set an “equal weight” rating and a $38.00 target price for the company. HC Wainwright lifted their target price on Cullinan Management from $47.00 to $48.00 and gave the stock a “buy” rating in a research report on Tuesday, March 30th. Finally, Evercore ISI initiated coverage on Cullinan Management in a research report on Tuesday, February 2nd. They set an “outperform” rating and a $55.00 target price for the company.

The business’s 50 day moving average price is $43.50.

Cullinan Management Company Profile (NASDAQ:CGEM)

Cullinan Management, Inc, a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Its lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer.

Recommended Story: What is the Federal Reserve?

Receive News & Ratings for Cullinan Management Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cullinan Management and related companies with MarketBeat.com's FREE daily email newsletter.